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Background: Venovenous bypass has been the standard in relieving chronic total occlusions of iliac veins. The technical
feasibility of percutaneous recanalization was previously reported. Routine applicability of this technique in a wide
spectrum of lesions and patients, stent patency, and clinical outcome forms the basis of this presentation.
Methods: During a 9-year period, 167 limbs in 159 unselected patients in a consecutive series with post-thrombotic
chronic total occlusions of the iliac and adjacent vein segments underwent percutaneous attempts at recanalization.
Patients were not selected based on venographic appearance or extent of the lesion, or excluded because of a preemptive
choice of open venovenous bypass surgery.
Results: Percutaneous recanalization was successful in 139 of 167 limbs (83%), including patients with bilateral occlusions
and 14 patients with inferior vena cava filters incorporated in the treated occlusion. Median age was 53 years (range,
18-84 years). Thrombophilia was identified in 44 patients. Venous dermatitis/ulcer was found in 46% of the treated
limbs. Recanalization involved three or more totally occluded vein segments in 42% of the limbs. The cumulative
secondary stent patency rate at 4 years was 66%. The cumulative marked relief of pain and swelling at 3 years was 79% and
66%, respectively. Cumulative healing of venous ulcer at 33 months was 56%. Quality of life metrics improved
significantly.
Conclusions:Most femoroiliocaval chronic total occlusions lesions can be successfully recanalized percutaneously with very
little morbidity, minimal downtime, sustained long-term stent patency, and substantial clinical improvement. The
procedure has wide applicability in a broad spectrum of symptomatic patients, including those with extensive lesions, and
can be considered for routine use. ( J Vasc Surg 2009;50:360-8.)Venovenous bypasses using the saphenous vein1 or a
prosthesis2 have been the standard in the treatment of
symptomatic iliac vein occlusions. Early results of percuta-
neous endovenous recanalization in 38 limbs were de-
scribed in 2002.3 Since then, procedural success has in-
creased with experience, reducing the need for open
venovenous bypass procedures. This study analyzed the
success rate, stent patency rate, and clinical outcomes in
patients after stent recanalization of chronic total occlu-
sions (CTO) of femoroiliocaval vein segments.
METHODS
Patients. From 1999 through 2007, obstructive le-
sions of the femoroiliocaval veins segments were treated by
stent placement in 1402 limbs; of these, 603 were post-
thrombotic which included CTO limbs. A consecutive
series of 167 limbs in 159 patients with femoroiliocaval
CTO underwent attempts at percutaneous recanalization
during that time. No limbs were excluded because of the
extent or severity of CTOor because of a preemptive choice
of venovenous bypass. In seven patients a previous veno-
venous bypass (3 prosthetic, 4 Palma) had been performed,
and five had occluded. Two Palma bypasses had remained
patent; however, the patients continued to be symptom-
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360atic. Limbs with acute or acute/chronic thromboses re-
quiring thrombolysis before stenting were excluded be-
cause these subsets were considered different from CTO
limbs. The procedure was successful in 139 limbs, repre-
senting 23% of all post-thrombotic limbs treated with
stents.
Preoperative investigations, indications, technique, and
follow-up protocol have been described in detail else-
where4-6 and are presented here in abbreviated form.
Indications. Patients with significant limb symptoms,
including pain, swelling, venous dermatitis and ulcer, re-
current cellulitis, or a combination of these symptoms, who
had failed conservative therapy were considered for inter-
vention. Severity of symptom presentation, and not the
venographic finding of CTO, was the determinant for
intervention; some patients with extensive venographic oc-
clusive lesions may be asymptomatic or only mildly symp-
tomatic.
A preoperative thrombophilia workup, consisting of
antithrombin 3, protein C and S, anticardiolipin antibody,
lupus anticoagulant, prothrombin and Leiden gene muta-
tions, and homocystinemia 15 mg, was routinely per-
formed. Venous investigations included arm/foot venous
pressure differential, ambulatory venous pressure measure-
ment, air plethysmography, duplex ultrasound (DUS) ex-
amination, and ascending (pedal contrast injection) and
transfemoral antegrade venography with exercise femoral
pressure measurement.
After recanalization, patients were monitored by clini-
cal examination at 6 weeks, 3 months, 6 months, and at
yearly intervals thereafter. The cumulative rate of ulcer
healing (100% epithelialization) was calculated. Pain was
JOURNAL OF VASCULAR SURGERY
Volume 50, Number 2 Raju and Neglén 361evaluated using a visual analog scale (VAS)7 from 0 to 10,
wherein 10 is the most severe pain. Swelling was assessed
as grade 0 (absent), grade 1 (pitting, not obvious), grade
2 (visible ankle edema), and grade 3 (gross, encompassing
the entire leg) according to reporting standards. The
ChronicVenous InsufficiencyQuestionnaire (CIVIQ)quality
of life method8 validated for chronic venous disease was
used, and the latest patient response was used in outcome
analysis. Contrast venography was routinely performed at 6
to 12 weeks, at 6 months after the procedure, and then
yearly. DUS examination, as recently described by Labro-
poulos et al,9 has been increasingly used to assess the
patency of the stented iliac vein. Preliminary experience
indicates the method is comparable to venography in as-
sessing gross stent patency.
Technique of recanalization. The procedure is per-
formed under general anesthesia for safer cardiopulmonary
control and lack of adequate pain control under local
anesthesia. A midthigh femoral vein access under US guid-
ance is used. The femoral vein is found posterolateral to the
artery at midthigh level. Progressive dilatation of the access
needle track with over-the-wire dilators may be required in
post-thrombotic veins before the introduction of the
sheath. With routine use of a sealing device (VasoSeal,
Datascope Corp, Montvale, NJ), access site complications
are rare. With attention to depth markings on the device,
inadvertent intravenous placement of the sealant is avoided
(1 suspected in 1500 uses), even when large sheaths are
used.
The midthigh access allows the use of shorter-length
instrumentation with superior pushability compared with
popliteal or internal jugular access. Sufficient space remains
cephalad to the sheath (size 10-13, 13-cm length) below
the inguinal ligament to deploy a stent into the common
femoral vein if needed. When the femoral vein is occluded,
as is frequently found, access is often possible through the
upper 3 to 5 cm of the vein, which tends to remain open, or
through parallel collaterals in the vicinity. The profunda
femoris vein is usually open if the femoral vein is occluded
and can be accessed 2 to 5 cm below the lesser trochanter.
When access is possible only in the upper thigh, the sheath
tip has to be withdrawn below the common femoral vein
for stent deployment if needed; stent extension into the
profunda femoris vein is allowed when the femoral vein is
occluded.
An antegrade venogram is performed to define existing
venous anatomy. A 0.035-inch soft or stiff Glidewire
(Terumo Inc, Ann Arbor, Mich) is inserted up to the
occlusion. Further progress into the occlusion is made
with the tip of the Glidewire with straight or angled
catheter support. Unlike in arterial occlusions, a leading
loop is not helpful at this stage. Cutting balloons and
tunneling devices (Frontrunner CTO, LuMend Inc, Red-
wood City, Calif) may be helpful to gain initial entry into
the occluded segment. After gaining access into the oc-
cluded vein, further progress into the occlusion is made
with the Glidewire tip, with or without catheter (or long
sheath) support. A leading loop may be advantageous togain passage through the external and common iliac veins if
the trabeculae are not dense.
A low-profile catheter with a sharp edge (Quick-Cross
catheter; Spectranetics, Colorado Springs, Colo) appears to
facilitate progress, but other hydrophilic catheters, either
4F or 5F size with standard or angled tips, are helpful as
well. If forward progress stalls, other Glidewires of different
stiffness, caliber, or tip angle should be tried. Usually, some
combination of Glidewire and supporting catheter will be
found to advance progress. Passage of the Glidewire
through the occluded segment meets with variable diffi-
culty. With some experience, most occluded iliofemoral
veins can be recanalized in 30 to 40 minutes and even
extensive inferior vena cava (IVC) occlusions in 60 to 75
minutes. The progress is sometimes tedious and patience is
necessary.
The Glidewire probably advances through small vascu-
lar channels present in the organizing fibrous tissue within
the vein. Because the occluded vein segment remains invis-
ible on venography, Glidewire passage must be guided by
intuitive sense of the normal anatomic course of the vein. In
the frontal projection, the left femoral vein overlies the
medial third of the femoral head, coursing up to the lower
pelvic brim over the pelvic tubercle, and from there bows
slightly outward, moving across the sacroiliac joint joining
the IVC variably between the fourth and fifth lumbar
vertebral bodies at their right margin. The right femoral
and iliac veins course in a straighter line (frontal projection)
to their junction with the IVC. The Glidewire should track
accordingly. It is useful to view progress of the recanaliza-
tion intermittently by 45° or 60° oblique projections to
ensure that the Glidewire initially follows the curve of the
sacrum and then turns anteriorly towards the promonto-
rium and anterior to the spine.
Progress of Glidewire passage through the occluded
vein may be impeded to a variable degree by vascular and
ligamentous structures compressing the vein. The post-
thrombotic fibrous tissue in and around the affected vein is
particularly dense at these anatomic “chokepoints,” where
compression occurs and post-thrombotic recanalization is
known to be poor.10-12 These sites differ between the right
and left sides (Fig 1). Intermediate balloon dilatations to
facilitate Glidewire passage are often counterproductive
because the wire loses the support of surrounding tissue
and coils in the dilated space, making further progress even
more difficult. The Glidewire may be diverted into collat-
erals and tributaries, particularly adjacent to these choke-
points. This is easily recognized if normal anatomy is kept in
mind.
An angled-tip catheter is useful in redirecting the
Glidewire in the proper direction when it seems to veer off
course. In a few instances, the Glidewire has passed through
the vertebral veins into the vertebral canal where it is
positioned in the middle of the vertebral column rather
than at the right lateral edge where the IVC is situated. This
is easily recognized by oblique fluoroscopic projections.
The Glidewire is withdrawn and redirected with no com-
plications.
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of the vein with sudden ease denotes perforation. The
Glidewire can be withdrawn and usually manipulated in the
proper direction without sequelae. Withdrawal of blood
through the catheter may or may not be possible during the
recanalization process and has no particular significance
(procedure may not be aborted) as long as the Glidewire
tracks approximate to normal anatomy.
Approaching the IVC, the Glidewire can track parallel
to the vena cava, possibly within the vasa vasorum in its
wall, for 3 to 5 cm before entering the proper lumen of the
IVC. This is not harmful. Interval contrast injections into
the track are usually not helpful, and pooling of the dye into
lakes can be misleading and should not suggest that the
Fig 1. The Glidewire passage during recanalization procedure
commonly meets resistance at several anatomic chokepoints where
the iliac or the hypogastric artery crosses the vein; the inguinal
ligament and the diaphragmatic hiatus may also prevent passage.
Relevant arterial crossover levels differ slightly between the right
and left side, as shown. The Glidewire can veer off course from the
main vein through tributaries and collaterals (shown numbered)
when meeting resistance. On the right side, the Glidewire may
enter medial or lateral collaterals because the iliac vein runs a
straighter course to the inferior vena cava. The left iliac vein has a
convex curvature, and the Glidewire tends to enter lateral tributar-
ies, usually the ascending lumbar vein. When the suprarenal vena
cava is occluded, the azygos and hemiazygos collaterals are en-
larged and the Glidewire enters them frequently. 1, Phrenic vein; 2,
azygos/hemiazygos complex; 3, prevertebral plexus; 4, hypogas-
tric vein; 5, ascending lumbar vein; 6, tributaries from the iliopsoas
muscles; 7, femoral vein tributaries; 8, lumbar veins.procedure be aborted.Entry into the IVC is verified by further easy passage of
the wire or catheter along the normal course of the vessel
into the right atrium. This should be confirmed by fluoros-
copy, contrast injection through a catheter placed in the
IVC, and intravascular US (IVUS). From this stage of the
recanalization procedure, the use of IVUS13 becomes cru-
cial to assure integrity of the recanalized channel, to select
optimal proximal and distal landing sites preferably free of
post-thrombotic disease, to ensure proper deployment and
expansion of the stents, and to minimize radiation expo-
sure. Venography alone is distinctly inferior in these re-
spects, and exclusive dependence on it may result in an
inferior outcome with poor patency.
The recanalized channel may be dilated in a single step
to the ultimate desired size after IVUS examination. Predi-
latation up to 10 mm may be necessary, starting with
smaller-sized (3-mm) balloons and matched guidewires in
some cases to gain easy passage of a 6F IVUS catheter and
large-caliber balloons. By IVUS, the Glidewire is invariably
found to lie within the confines of the recanalized occluded
vein (Fig 2).
Repeated balloon dilatation at the anatomic choke-
points may be necessary. It is useful to use high-pressure
balloons (16 to 18 atm) and keep the balloon expanded at
maximum level for at least a minute until the balloon
pressure stabilizes at this level. Overdilatation and oversiz-
ing of the stent diameter by 2 to 4 mm for the anatomic
location is recommended to compensate for the variable
recoil of the recanalized channel. Oversizing the vena caval
stent is important to facilitate later contralateral stenting if
required. Optimal stent diameters after recoil are 20 mm
for the IVC, 16 to 18 mm for the common iliac vein, 14 to
16 mm for the external iliac vein, and 12 to 14 mm for the
common femoral vein in normally sized adults.
Self-expanding woven braided stainless stents (Wall-
stent, Boston Scientific, Nantucket, Mass) in series with 3-
to 5-cm overlap to minimize shelving along the complex
course of the iliac vein were used in most patients (Fig 3). A
smooth transition at overlaps is facilitated by using stents
with the same diameter (used for the largest segment)
through all of the recanalized segments, but limiting post-
deployment balloon dilatation to the size appropriate for
each segment. This results in oversizing of the stents, which
is an advantage during later interventional corrections, if
needed.
Because multiple stents are typically required, the max-
imum manufactured length for the various diameter sizes
(typically 7- to 9-cm length) should be used, restricting
shorter lengths for use at either end of the stack to tailor
length. Unless the recoil is severe (40%), dilatation after
deployment should be delayed until all of the stents are in
place. This speeds up restoration of flow through the stent
assembly and helps to reduce the chances of thrombus
nidus formation. A completion IVUS examination and
venogram terminate the procedure after noted defects are
corrected by repeat ballooning. Patients can be discharged
after an overnight stay.
isual
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cluded caval segment or present above the occlusion in a
patent segment pose a special technical problem. In the
former instance, the filter must be displaced sideways or
remodeled/fractured by repeated high-pressure balloon
dilation to allow stent placement.14 In the latter case, the
filter implantation site must be assessed for significant asso-
ciated stenosis. If present, the IVC filter should be dis-
rupted or displaced for placement of the stent across the
stenosis; otherwise, it is left alone (Fig 4). Balloon dilata-
tion of filter-associated stenoses has been surprisingly easy
with routine technique; there is little recoil, probably be-
cause the stenosis is predominantly intraluminal with little
perivenous component.
Bilateral iliofemoral vein recanalizations are performed
at the same session or staged, depending on the duration
and difficulty of the initial procedure. The right and left
Fig 2. Recanalization of an occluded iliac vein. Left pa
the occluded vein and deployment of a slightly oversized
normal anatomy. This poses no bleeding risk (see text)
recanalized channel after maximal balloon dilatation invar
with intact thick walls. Right panel, Completion veno
residual stenoses, good flow, and absence of previously v
Fig 3. Left, Frontal projections obscure the complex c
occurs at the L5-S1 vertebral junction (arrow, Left and R
compromising effective in-stent lumen, may occur if sten
problem is to center a long (9-cm) stent initially over L5
situated away from this point.stent assemblies are connected through a fenestration cre-ated in the side of the initial stent assembly.14 The tech-
nique is described in detail elsewhere.15
Anticoagulation. Bivalirudin (50 mg) or unfraction-
ated heparin (5000U) is administered intravenously during
the procedure. Low-molecular-weight heparin (dalteparin,
2500 U subcutaneously) is administered before the proce-
dure, afterwards in the recovery room, and daily thereafter
for 3 to 5 days. Earlier in this experience, only aspirin was
used empirically for long-term stent maintenance, except in
cases of thrombophilia when warfarin was instituted or
continued after recanalization. Currently, fondaparinux so-
dium is used in all patients for 4 to 6 weeks after recanali-
zation. A prophylactic dosage is used except in cases of long
recanalizations (3 segments), suprarenal stent place-
ments, thrombophilia, or in patients receiving long-term
anticoagulation; in these patients, the therapeutic dosage is
used. Long-term warfarin is indicated in most of these
nitial venogram. Second panel, Aggressive dilatation of
is required to achieve a recanalized lumen approximating
ird panel, Intravascular ultrasound examination of the
shows the Glidewire in the middle of the venous channel
shows a stented channel of adequate lumen without
ized collaterals.
of the iliac vein through the pelvis. Right, A 50° turn
), evident on lateral projection. “Shelving” of stent ends,
laps are placed near this location. A strategy to avoid this
nction and add proximal and distal stents with overlapsnel, I
stent
. Th
iably
gramourse
ight
t over
-S1 jupatients.
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analyzed by paired nonparametric Wilcoxon signed rank
test and 2 test, respectively. Primary, assisted-primary,
and secondary patency rates, as well as clinical outcome
were calculated using survival analysis with the Kaplan-
Meier method. Prism 3 software (GraphPad, San Diego,
Calif) was used for analysis. A value of P  .05 was
considered significant.
RESULTS
The procedure was successful in 139 of 167 limbs in
131 of 159 patients.Median age was 53 years (range, 18-92
Fig 4. Staged bilateral recanalization. The left iliac vein and the
infrarenal vena cava with an inferior vena cava filter incorporated in
the occlusion were recanalized first. The filter was ballooned and
stented across. The right iliac vein was recanalized a few weeks
later, connecting the two sides through a fenestration (see text).
Bilateral excoriative dermatitis with lymph leak healed soon there-
after. This 92-year-old patient was not a candidate for open sur-
gery.
Table I. Basic CEAP classification of 139 recanalized
limbs
CEAP classification No.
Clinical
C2: varicose veins 3
a
C3: edema 71
C4a: pigmentation or eczema 14
C4b: lipodermatosclerosis or white scar 8
C5: healed venous ulcer 11
C6: active venous ulcer 32
Etiologic
Ep: primary 0
Es: secondary 139
Anatomicb
Ad: deep veins 39
As,d: superficial and deep veins 76
Ad,p: deep and perforator veins 3
As,d,p: superficial, deep, and perforator veins 19
Pathophysiologicb
Po: obstruction 26
Pr,o: reflux and obstruction 111
aAll had severe limb pain.
bAnatomic and pathophysiologic classes are missing for two patients.years). Female to male ratio was 2:1, and left to right limbratio was 4:1. Bilateral occlusions were present in 14 pa-
tients, and recanalization was successful in both limbs in
eight patients (simultaneously in 4 and staged in 4) and in
one of the two limbs in three patients, but failed in three
patients. Significant thrombophilia was found in 44 stented
Fig 5. Cumulative primary, assisted-primary, and secondary pa-
tency rates of femoroiliocaval stents placed in recanalized occluded
limbs. The lower numbers represent limbs at risk for each time
interval (all standard error of the mean 10%).
Table II. Anatomic distribution of recanalized vein
segments in 139 limbsa
Recanalized Recanalized
Segment No. Segment No.
CFV 4 IVCir, CIV, EIV, CFV 10
EIV, CFV 5 IVCsr, IVCir 1
CIV 27 IVCsr, IVCir, CIV 2
CIV, EIV 36 IVCsr, IVCir, CIV, EIV 3
CIV, EIV, CFV 32 IVCsr, IVCir, CIV, EIV, CFV 1
IVCir 4 IVCth, IVCab, CIV 1
IVCir, CIV 4 IVCth, IVCab, CIV, EIV, CFV 1
IVCir, CIV, EIV 7 IVCat, IVCsr, IVCir, CIV, EIV 1
CFV, Common femoral vein; CIV, common iliac vein; EIV, external iliac
vein; IVC, inferior vena cava; IVCat, inferior vena cava-atrial junction;
IVCir, infrarenal vena cava; IVCsr, suprarenal vena cava; IVCth, thoracic
vena cava; IVCab, abdominal vena cava.
aOf the 139 limbs, 35 (25%) had recanalization of one segment; 46 (33%)
had recanalization of two segments; 58 (42%) had recanalization of three or
more segments.
Table III. Procedure success in 139 recanalized limbs by
number of attempts at recanalizationa
Attempt No. %
First 121 87
Second 10 8
Third 6 4
Fourth or moreb 2 1
aRecanalization was ultimately successful in 139 of 167 limbs (83%).
b1 limb on the fifth attempt; 1 limb on the sixth attempt.patients (34%). CEAP classification of recanalized limbs is
n sele
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segments of the limbs is summarized in Table II. A total of
14 IVC filters of various types were remodeled and stented
through, without any apparent complications. No associ-
ated stenosis was found in two other limbs, and the filter
was left undisturbed above the stent. No pararenal or
suprarenal filters were encountered in this experience.
The upper and lower landing sites of the stents com-
monly extended one or more segments beyond the recana-
lized section to cover adjoining nonocclusive stenoses. The
lower landing site of the stent was below the inguinal
ligament (common femoral vein) in 65 limbs (47%), in the
external iliac vein in 42 (30%), and in the common iliac vein
in 32 (23%). The upper landing site was in the IVC in all
but two limbs for previously described technical reasons.4
These two limbs had distal external iliac vein occlusion, and
the upper landing site was in the common iliac vein.
Procedural success. The overall recanalization success
rate was 83% (139 of 167 limbs), andmost procedures were
successful on the first attempt (Table III). Recanalization
failed in two of five patents with occluded venovenous
bypasses performed earlier because the prior venotomy site
could not be traversed. Endophlebectomies16 of the fem-
oral vein were performed in seven limbs that were impervi-
ous to percutaneous entry into the occluded femoral vein
segment. Subsequent recanalization was attempted in five
limbs, but succeeded only in two limbs, both of which later
occluded.
Morbidity. There was no 30-day mortality. There was
no clinically apparent procedurally related bleeding. (A
contained pelvic hematoma requiring transfusions oc-
curred in one patient in 2008 who was not included in this
series.) No access complications occurred that required
intervention. About 25% of the patients reported back pain,
which was limited (commonly days, occasionally up to 2
weeks) and easily controlled with ibuprofen. No patient
required hospitalization for pain. One patient had a contrast-
related transient rise in the serum creatinine concentration.
Early thrombotic events (30 days after stenting) occurred
Fig. 6. Removal of an occluded Wallstent through a li
strands under fluoroscopy (arrow) will result in unraveli
strands. The technique may allow repeat recanalization iin 10 limbs, all associated with concurrent thrombosis ofthe stent. Late thrombotic events (30 days after stenting)
occurred in 32 limbs (ipsilateral, involving the stent in 29;
contralateral nonstented limbs in 3 patients).
Stent patency. Long-term primary, assisted-primary,
and secondary patency rates are shown in Fig 5. During the
follow-up period, 39 stents (28%) occluded, including one
patient in whom the lower portion (common femoral in-
flow) has occluded and only the upper part of the stent
stack is open (hypogastric inflow through the stent weave).
Stent thrombosis was unrelated to preexisting thrombo-
philia (P  .68). Pharmacomechanical thrombectomy or
catheter-directed thrombolysis, or both, were attempted in
23 limbs with occluded stents. This was successful in restor-
ing stent patency in 17 limbs; 10 remained patent, but
seven later occluded. One occluded stent spontaneously
lysed after having been occluded for 3 years, and both
occurrences were confirmed by transfemoral venography.
An adjunctive arteriovenous fistula to improve inflow after
thrombectomy was used in one patient, but the stent
rethrombosed. In two limbs, the occluded iliac stent was
removed (Fig 6) through a limited transverse venotomy.
One limb was recanalized and restented later, but throm-
bosed 6 weeks.
Other reinterventions. Precautionary reinterventions
were completed in 38 recanalized limbs (27%; Table IV).
Indication for reintervention was the presence of significant
Table IV. Details of reintervention procedures in 38
recanalized limbs
Reintervention procedure No. (n  38)
Balloon dilation 22
Plus add proximal stent 2
Plus add distal stent 8
Plus add proximal and distal stents 1
Plus add stent separation stent 2
Add proximal stent 1
Removal of Wallstent; restented 2
transverse venotomy. Left, Steady pull on one of the
the stent weave and (Right) serial removal of all of the
cted cases.mited
ng of(50%) in-stent restenosis or residual or recurrent symp-
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niques performed in stented patients, including the recana-
lized CTO subset, are described elsewhere.17
Clinical outcome. Cumulative curves representing
symptom relief (pain, swelling, skin changes) are shown in
Figs 7-9. Quality of life metrics before and after recanaliza-
tion are reported in Table V. Significant improvement was
seen in all categories. Six patients in whom recanalization
failed or occluded later underwent a venovenous bypass,
and the others either declined the procedure or were not
considered appropriate candidates for the open procedure.
Hemodynamics. Hemodynamic parameters before
and after recanalization and stenting are summarized in
Table VI. No improvement was noted. No hemodynamic
Fig 7. Cumulative partial, defined as 3 of 10 on the visual
analog scale (VAS), and complete relief of pain after recanalization
and stenting. The lower numbers represent limbs at risk for each
time interval (all standard error of the mean 10%).
Fig 8. Cumulative partial (1 grade) and complete relief of
swelling after recanalization and stenting. The lower numbers
represent limbs at risk for each time interval (all standard error of
the mean 10%).values deteriorated, including reflux parameters.DISCUSSION
Current endovascular techniques are largely derived
from arterial experience. The venous system obviously dif-
fers from the arterial system in many respects. Prevailing
pressure is low, although flow is high due to larger conduit
size; obstructive lesions result from post-thrombotic fibro-
sis both inside and around the vein, quite different from
atherosclerotic lesions; and extravenous compressive bands
and associated enhanced perivenous fibrosis contribute to
the obstructive pathology. The response of large venous
conduits to prosthetic metal is also different from arterial
Fig 9. The upper curve shows cumulative freedom from derma-
titis/ulcer in limbs with clinical severity (C) class 4 and 5 by CEAP
after recanalization and stenting. The lower curve shows cumula-
tive rate of healed leg ulcers (C6 in CEAP) after recanalization and
stenting. Limbs with ulcers that never healed after stenting were
censored at the 3-month follow-up. Ulcers that healed and subse-
quently recurred were censored at the time of recurrence. The
incidence of recurrence is very low after primary healing, resulting
in a flat curve. The lower numbers represent limbs at risk for each
time interval (all standard error of the mean 10%).
Table V. Quality of life assessment values (Chronic
Venous Insufficiency Questionnaire) before and after
recanalization in 128 limbs
Value
Total score (mean  SD)
Before After
Leg pain (none  1, max score, 5) 3.5  1.3 2.6  1.3a
Work-related leg problem (not
bothered  1; max score, 5) 3.7  1.3 2.9  1.2a
Sleep disturbance due to leg
problems (never  1; max
score, 5) 3.2  1.3 2.5  1.3a
Effect on social activities (none  8;
max score, 40) 26.8  8.8 21.3  8.7a
Effect on morale (none  9; max
score, 45) 26.4  11.1 21.6  8.8a
aP .001.experience. The incidence of in-stent restenosis is less,18
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Braided venous stents can be extended across flexion
creases.20 Stent fractures and erosions are rare, probably
because pulsatile flow causing intravessel stent motion and
metal fatigue is absent.
These differences pose advantages as well as challenges
in adapting endovascular techniques to venous use. For
example, deep veins can be directly accessed nearer the
lesion without fear of hemorrhage, and the midthigh access
resulted in successful recanalization of CTO lesions after
attempts through traditional access points had failed. Ag-
gressive balloon dilatation and overdilatation can be per-
formed safely.
Extraluminal excursions of the guidewire, limited per-
forations, and leaks during recanalization maneuvers need
not abort the procedure prematurely. On the other hand,
undersizing of stents and residual stenoses at the inflow or
outflow portions of the stented conduit are less well toler-
ated (poor symptom relief) than in the arterial system.
Modifications of standard technique, as suggested in the
previous section, may increase procedure success, stent
patency, and clinical outcome in treating iliac vein CTO
lesions.
Most femoroiliocaval CTOs, even if extensive, can be
successfully recanalized percutaneously. Repeat attempts
are warranted if the initial recanalization fails. Some short
lesions may be surprisingly difficult or impossible to tra-
verse, particularly those involving occlusion of the common
femoral vein. Stenting across previously placed IVC filters,
even when incorporated in the occluded vein segment, can
be successful.14,21
The stented recanalized channel must be of adequate
caliber, approximating normal anatomy, to provide unre-
stricted flow and decompress the limb to relieve symptoms
and maintain long-term patency. Stenotic lesions adjacent
to the recanalized segment should be stented without
concern for the ensuing length of the stent assembly. The
stent may be safely extended across the groin crease in
pursuit of this objective.20 The metal load is seldom the
cause of stent thrombosis, even in thrombophilic patients.
The use of IVUS is critical to ensure a satisfactory technical
outcome, minimize the need for reinterventions, and max-
Table VI. Hemodynamic parameters before and after reca
Variable No.
Hand-foot pressure differential, mmHg 33
Ambulatory venous pressure
% drop 37
Venous filling time, s 36
APG
VFI90, mL/s 58
Ejection fraction, % 55
RVF, % 49
APG, Air plethysmography; RVF, residual volume fraction; VFI90, venous
aNone of the values for P are significant.imize symptom relief when venous lesions are treated.17Some inflow problems may be impossible to correct
because of the severity of post-thrombotic disease involving
the femoral and profunda femoral vein segments. Cur-
rently, there is no reliable way to assess preoperatively the
potential adequacy of inflow. Several patients with severe
post-thrombotic disease of the inflow tract in this study
have had good clinical outcome, with long-term stent
patency. Inflow can be grossly assessed intraoperatively by
the speed of contrast clearance during completion venog-
raphy.
Although rapid clearance is reassuring, the opposite
does not necessarily warn of failure. The large sheath used
during the recanalization procedure may itself impede in-
flow into the stent in some cases. When clearance is slow,
adequate postoperative anticoagulation and close stent sur-
veillance must be ensured. More frequent surveillance is
now possible with DUS imaging.
The perioperative anticoagulation protocol is empiric.
Risk of hemorrhage has to be balanced with the desire to
maintain stent patency during and after the procedure. Full
anticoagulation during the procedure has not been found
to be necessary, and no stent thromboses during the pro-
cedure have occurred. There is room for improvement in
the postoperative anticoagulation protocol to reduce de-
layed stent thromboses. We have not routinely used arte-
riovenous fistulas22,23 to assist stent patency.
Open venovenous bypasses are major procedures, and
application has been limited by age or other comorbidities.
The resulting scar (Palma procedure) in the thigh is a
disadvantage. Reported patency of venovenous bypass pro-
cedures has been variable.23-27 Symptoms may persist de-
spite a patent Palma bypass, as occurred in some patients in
this series, because of the restricted size of the saphenous
conduit.
CONCLUSIONS
Percutaneous recanalization is minimally invasive, safe,
efficacious, and associated with negligible morbidity and
downtime; therefore, it can be used in a broad spectrum of
patients in whom an open bypass procedure will be pre-
cluded or inappropriate because of age (the oldest in this
series was 92), symptom severity, and comorbidities. These
ation
Before After
PaMedian (range) Median (range)
2 (0-22) 1 (0-8) .0688
63.5 (0-100) 61 (19-97) .8044
17 (1-336) 18 (1-120) .1199
2.7 (0.4-16.6) 2.3 (0.04-12.2) .4326
47 (11-100) 44 (5-100) .7445
32 (0-100) 28 (0-100) .6386
ndex.naliz
filing iadvantages place the procedure as the first choice in treating
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August 2009368 Raju and Neglénsymptomatic femoroiliocaval vein occlusion. If stenting
were to fail, subsequent open surgery would not be pre-
cluded. The open vein segment below the occluded stent or
the occluded femoral vein after endovenectomy, combined
with partial resection of the occluded stent, can then be
used for inflow to the bypass. Conversely, prior failed open
surgical interventions in the groin area (venovenous by-
pass) and the resulting dense fibrosis may render the per-
cutaneous recanalization technically impossible.
A current deficit is the absence of a reliable tool to assess
hemodynamic severity.6,12 If available, such a metric would
be expected to be grossly abnormal in CTO lesions. None
of the currently available techniques are useful in this
respect. Selection of patients for intervention continues to
be based on symptom severity and morphologic assessment
of obstruction.
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